Bausch Health Companies (BHC) Net Cash Flow (2009 - 2026)

Bausch Health Companies (BHC) reported Net Cash Flow of -$9.0 million for Q1 2026, up 86.15% on a YoY basis from -$4.8 million in Q1 2025, and up 59.09% sequentially from -$22.0 million in Q4 2025.

Bausch Health Companies (BHC) Net Cash Flow (2009 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 18 years of Net Cash Flow data on file, last reported at -$9.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Net Cash Flow rose 86.15% year-over-year to -$9.0 million; the trailing twelve-month figure through Mar 2026 stood at $119.0 million (down 71.12% YoY), and the FY2025 full-year result was $63.0 million, down 77.09% from the prior year.
  • Net Cash Flow climbed to -$9.0 million in Q1 2026, from -$22.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $547.0 million in Q2 2025 to a low of -$1.4 billion in Q3 2022.
  • A 5-year average of -$47.9 million and a median of -$9.0 million in 2026 frame the typical range for Net Cash Flow.
  • Across the five-year window, Net Cash Flow sank 26940.0% in 2022 and jumped 544.72% in 2025, its largest moves.
  • Tracing BHC's Net Cash Flow over 5 years: stood at $63.0 million in 2022, then jumped by 158.73% to $163.0 million in 2023, then jumped by 198.16% to $486.0 million in 2024, then slumped by 104.53% to -$22.0 million in 2025, then surged by 59.09% to -$9.0 million in 2026.
  • Business Quant data shows BHC's Net Cash Flow at -$9.0 million in Q1 2026, -$22.0 million in Q4 2025, and -$397.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 202.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -526.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 711.50 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -277.40 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 461.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -446.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -112.00 Mn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn -9.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.00 Mn
Mar 31, 2026 -9.00 Mn
Dec 31, 2025 -22.00 Mn
Dec 31, 2025 -22.00 Mn
Sep 30, 2025 -397.00 Mn
Sep 30, 2025 -397.00 Mn
Jun 30, 2025 547.00 Mn
Jun 30, 2025 547.00 Mn
Mar 31, 2025 -65.00 Mn
Mar 31, 2025 -65.00 Mn
Dec 31, 2024 486.00 Mn
Dec 31, 2024 486.00 Mn
Sep 30, 2024 114.00 Mn
Sep 30, 2024 114.00 Mn
Jun 30, 2024 -123.00 Mn
Jun 30, 2024 -123.00 Mn
Mar 31, 2024 -202.00 Mn
Mar 31, 2024 -202.00 Mn
Dec 31, 2023 163.00 Mn
Dec 31, 2023 163.00 Mn